Stanford researchers have found a way to predict who will suffer heart problems from a common breast-cancer drug, as well as identified an FDA-approved medication that could mitigate those side effects.
Stanford researchers have found that transient changes in the numbers and activation levels of a handful of circulating immune cell types can predict the likelihood of dementia one year after a stroke.
The role of democracy in public health leads to dramatic decreases in deaths from noncommunicable diseases, HIV, cardiovascular disease and transportation injuries, according to a new study by researchers at Stanford and several other institutions.
Some breast cancers return decades later. Now, a researcher at Stanford, joined by collaborators at several other institutions, has subcategorized tumors to predict recurrence, guide treatment decisions and improve drug development.
Inside Stanford Medicineis a twice-monthly newspaper that reports on the accomplishments and activities of the faculty, staff and students in the Stanford Medicine community. To suggest a story or to get more information, contact editor John Sanford at (650) 723-8309 or firstname.lastname@example.org.
You're receiving this newsletter because you registered with us.
Not interested anymore? Unsubscribe here.